Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Nexium
|
| gptkbp:approves |
gptkb:2001
|
| gptkbp:brand |
gptkb:Nexium
|
| gptkbp:category |
Category B
|
| gptkbp:contraindication |
severe liver disease
hypersensitivity to esomeprazole |
| gptkbp:dosage_form |
20 mg
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nexium 24 HR
|
| gptkbp:indication |
heartburn
erosive esophagitis |
| gptkbp:ingredients |
esomeprazole magnesium
|
| gptkbp:interacts_with |
gptkb:methotrexate
gptkb:clopidogrel gptkb:warfarin |
| gptkbp:is_atype_of |
A02 B C05
|
| gptkbp:is_available_on |
gptkb:drug
|
| gptkbp:is_part_of |
Nexium product line
|
| gptkbp:is_used_for |
treatment of gastroesophageal reflux disease (GERD)
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:temple
|
| gptkbp:side_effect |
headache
nausea abdominal pain diarrhea flatulence |
| gptkbp:social_structure |
C17 H18 N3 O3 S
|
| gptkbp:storage |
store at room temperature
|